Drugs / fig extract
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02338336 | Feb → Sep 2015 | plantar wart | Nowarta Biopharma Inc | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | fig extract | “Nowarta110 contains fig extract as the main drug substance, and colloidal silver is used as a medium for penetration of fig extract into the wart lesion.” NCT02338336 ↗ |
| Route | Topical | “Liquid for topical administration.” NCT02338336 ↗ |